Skye continues to expect topline clinical data from the CBeyond Expansion Study in Q4 2026. The study is designed to generate higher-exposure human safety and pharmacokinetic data to inform dose ...

Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD continuing as planned based on independent DMC review of ...

Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, ...

Specialty Cancer Diagnostics Company Focused on Creating Cutting-Edge Products for Laboratories Through a Unique ...

Oral presentation of data from RALLY-MF phase 2 trial of DISC-0974 in patients with myelofibrosis and anemiaAdditional abstracts highlighting ...

GT Rewards: Good Times brand's digital loyalty program designed to incentivize repeat customer visits and track member sales ...

The deal covers a production site in Coriano, in Rimini province, and the Unconventional 100% Vegetale brand.

Data from pivotal Phase 3 frontMIND trial evaluating tafasitamab (Monjuvi®/Minjuvi®) in first-line diffuse large b-cell lymphoma (DLBCL) selected for prestigious Plenary Abstracts SessionOral and ...

Operator: Ladies and gentlemen, greetings, and welcome to the Quantum Computing, Inc. First Quarter 2026 Shareholder Update ...

Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.

The Spring 2026 magazine cover starring Karol G established measurable audience growth, with physical copies selling out ...

The DoJ secured record-breaking False Claims Act recoveries of $6.8 billion in fiscal year 2025, with $76 million from the ...